ArticlePharmacoepidemiology and drug safety2020

Assessing the incidence of osteosarcoma among teriparatide users based on Medicare Part D and US State Cancer Registry Data.

Alicia Gilsenan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.